| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-0927-3 |
| P698 | PubMed publication ID | 14871976 |
| P2093 | author name string | Richard M Caprioli | |
| Robert J Weil | |||
| Mahlon D Johnson | |||
| Sarah A Schwartz | |||
| Steven A Toms | |||
| P4510 | describes a project that uses | mass spectrometry | Q180809 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain tumor | Q233309 |
| P304 | page(s) | 981-987 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression | |
| P478 | volume | 10 |
| Q33782146 | A computational algorithm for functional clustering of proteome dynamics during development |
| Q33250636 | A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer. |
| Q48846427 | All about DIGE: quantification technology for differential-display 2D-gel proteomics |
| Q28396816 | Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research. |
| Q34123308 | Automated MALDI matrix coating system for multiple tissue samples for imaging mass spectrometry |
| Q33299118 | Bootstrap classification and point-based feature selection from age-staged mouse cerebellum tissues of matrix assisted laser desorption/ionization mass spectra using a fuzzy rule-building expert system |
| Q41612167 | Characterization of internal structure of hydrated agar and gelatin matrices by cryo-SEM. |
| Q31158913 | Classification of premalignant pancreatic cancer mass-spectrometry data using decision tree ensembles |
| Q37137019 | Clinical proteomics and breast cancer: strategies for diagnostic and therapeutic biomarker discovery |
| Q42196276 | Cluster and Principal Component Analysis of Human Glioblastoma Multiforme (GBM) Tumor Proteome |
| Q36104523 | Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics |
| Q30002300 | Comprehensive comparison of large-scale tissue expression datasets |
| Q34778073 | Comprehensive identification of proteins from MALDI imaging |
| Q50746652 | Conference report--at the forefront of cancer research: clinical results highlights of the annual meeting of the 95th American Association for Cancer Research, March 27-31, 2004; Orlando, Florida. |
| Q94101606 | Current Awareness on Comparative and Functional Genomics |
| Q34777079 | Current frontiers in clinical research application of MALDI imaging mass spectrometry |
| Q30499021 | Direct tissue analysis by matrix-assisted laser desorption ionization mass spectrometry: application to kidney biology |
| Q33843479 | Elastic net-based framework for imaging mass spectrometry data biomarker selection and classification |
| Q33356041 | Exploring proteins in Anopheles gambiae male and female antennae through MALDI mass spectrometry profiling |
| Q36580350 | Frozen tissue biobanks. Tissue handling, cryopreservation, extraction, and use for proteomic analysis |
| Q24811788 | Functional clustering algorithm for high-dimensional proteomics data |
| Q35030055 | Imaging mass spectrometry: a new tool for pathology in a molecular age |
| Q33213530 | Imaging mass spectrometry: principles and potentials |
| Q33919463 | Imaging of intact tissue sections: moving beyond the microscope |
| Q33536079 | Imaging of meningioma progression by matrix-assisted laser desorption ionization time-of-flight mass spectrometry |
| Q28748900 | Increased phosphorylation of vimentin in noninfiltrative meningiomas |
| Q33856593 | Investigation of protein induction in tumour vascular targeted strategies by MALDI MSI. |
| Q33217472 | Isotope-differentiated binding energy shift tags (IDBEST) for improved targeted biomarker discovery and validation |
| Q57150291 | Label-free molecular imaging of the kidney |
| Q30938681 | MALDI FTICR IMS of Intact Proteins: Using Mass Accuracy to Link Protein Images with Proteomics Data |
| Q34454885 | MALDI MS imaging as a tool for biomarker discovery: methodological challenges in a clinical setting |
| Q30493634 | MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology |
| Q28480625 | MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer |
| Q30470146 | MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives |
| Q30489353 | MALDI tissue profiling of integral membrane proteins from ocular tissues |
| Q35092529 | MALDI-MSI and label-free LC-ESI-MS/MS shotgun proteomics to investigate protein induction in a murine fibrosarcoma model following treatment with a vascular disrupting agent |
| Q30475508 | Mass spectrometric imaging for biomedical tissue analysis |
| Q36680064 | Mass spectrometry: uncovering the cancer proteome for diagnostics |
| Q38010665 | Measuring molecular biomarkers in epidemiologic studies: laboratory techniques and biospecimen considerations |
| Q30475550 | Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma |
| Q42110076 | Molecular classification of brain tumor biopsies using solid-state magic angle spinning proton magnetic resonance spectroscopy and robust classifiers |
| Q33730394 | Molecular mass spectrometry imaging in biomedical and life science research. |
| Q33409559 | Multifarious proteomic signatures and regional heterogeneity in glioblastomas |
| Q33736511 | Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models |
| Q33364583 | NITPICK: peak identification for mass spectrometry data |
| Q33245203 | Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment |
| Q33329750 | Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes |
| Q33222950 | Proteohistography--direct analysis of tissue with high sensitivity and high spatial resolution using ProteinChip technology |
| Q33309684 | Proteomic analysis of gliomas |
| Q37405931 | Proteomic and metabolic prediction of response to therapy in gastrointestinal cancers |
| Q33223841 | Proteomic patterns of preinvasive bronchial lesions |
| Q36787244 | Proteomics in atherothrombosis: a future perspective |
| Q33215044 | Proteomics in cancer vaccine development |
| Q36192482 | Proteomics in clinical laboratory diagnosis. |
| Q30473125 | Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections |
| Q31105602 | Proteomics in pathology research. |
| Q35170365 | Proteomics of gliomas: initial biomarker discovery and evolution of technology |
| Q92089518 | Quantitative proteomics reveals reduction of endocytic machinery components in gliomas |
| Q36913050 | Recent advances in protein profiling of tissues and tissue fluids |
| Q30465139 | Recent advances in single-cell MALDI mass spectrometry imaging and potential clinical impact |
| Q33748119 | Reference spectra from squamous epithelium and connective tissue allow whole section proteomics analysis |
| Q37360227 | Signal transduction molecule patterns indicating potential glioblastoma therapy approaches |
| Q35822804 | Simultaneous detection of phosphatidylcholines and glycerolipids using matrix-enhanced surface-assisted laser desorption/ionization-mass spectrometry with sputter-deposited platinum film |
| Q30493588 | Sublimation as a method of matrix application for mass spectrometric imaging |
| Q34244676 | The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumor-relapse biomarker: evidence from mass spectrometry profiling. |
| Q33781313 | Trends in analytical atomic and molecular mass spectrometry in biology and the life sciences. |
| Q90646370 | Unsupervised machine learning for exploratory data analysis in imaging mass spectrometry |
| Q37086665 | Urine proteomics to detect biomarkers for chronic allograft dysfunction. |
Search more.